Zobrazeno 1 - 10
of 28
pro vyhledávání: '"CPAD"'
Autor:
CPAD
Por que a Assembleia de Deus no Brasil não usa cruz em suas fachadas? Como surgiu o perfil conservador em relação a usos e costumes, que caracteriza a identidade assembleiana? Quando e por que a Assembleia de Deus começou a usar o rádio na evang
Autor:
Zhao, Mei, Lv, Xiaozhen, Tuerxun, Maimaitirexiati, He, Jincai, Luo, Benyan, Chen, Wei, Wang, Kai, Gu, Ping, Kuang, Weihong, Zhou, Yuying, Qu, Qiumin, He, Jianhua, Zhang, Nan, Feng, Yongping, Wang, Yanping, Yu, Xin, Wang, Huali, Clinical Pathway for Alzheimer’s Disease in China (CPAD) investigators
Publikováno v:
International Psychogeriatrics; Feb2016, Vol. 28 Issue 2, p211-219, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mathisen GH; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway. gro.haarklou.mathisen@vkm.no., Bearth A; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway.; HF Partners, Tièchestrasse 63, 8037, Zurich, Switzerland., Jones LB; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway.; Department of Politics and International Relations, University of Sheffield, Sheffield, UK., Hoffmann S; Evidence-Based Toxicology Collaboration (EBTC), Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA.; Seh Consulting + Services, Paderborn, Germany., Vist GE; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway.; Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway., Ames HM; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway.; Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway., Husøy T; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway.; Department of Food Safety, Norwegian Institute of Public Health, Oslo, Norway., Svendsen C; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway.; Department of Chemical Toxicology, Norwegian Institute of Public Health, Oslo, Norway., Tsaioun K; Evidence-Based Toxicology Collaboration (EBTC), Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA., Ashikaga T; Division of Genome Safety Science/JaCVAM, Center for Biological Safety Research (CBSR), National Institute of Health Sciences (NIHS), Kawasaki, Japan., Bloch D; Department of Pesticides Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany., Cavoski A; Birmingham Law School, University of Birmingham, Birmingham, UK., Chiu WA; Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA., Davies HG; Department of Health, Washington State, Tumwater, WA, USA., Giusti A; Cosmetics Europe, Avenue Herrmann-Debroux 40, 1160, Auderghem, Belgium., Hartung T; Center for Alternatives to Animal Testing (CAAT), Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA.; CAAT Europe, University of Konstanz, Konstanz, Germany., Hirabayashi Y; Center for Biological Safety Research (CBSR), National Institute of Health Sciences (NIHS), Kawasaki, Japan., Hogberg HT; National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA., Joglekar R; Department of Obstetrics, Gynecology and Reproductive Sciences, Program On Reproductive Health and the Environment, University of California, San Francisco, USA., Kojima H; Division of Food Additives, National Institute of Health Sciences (NIHS), Kawasaki, Japan.; Faculty of Engineering, Sanyo-Onoda City University, Yamaguchi, Japan., Krishnan K; Air and Site Assessment and Climate Indicators Branch, Division of Scientific Programs, Office of Environmental Health Hazard Assessment, 1001 I Street, Sacramento, CA, USA., Kwon S; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119077, Singapore., Osborne OJ; Chemical Risk Assessment Team, Science, Evidence and Research Division, Food Standards Agency, Petty France, Westminster, London, SW1H 9EX, UK., Roggen E; 3Rs Management and Consulting ApS, Lyngby, Denmark., Rooney AA; Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA., Rousselle C; French Agency for Food, Environmental and Occupational Health and Safety (ANSES), 94701, Maisons-Alfort, France., Sass JB; Natural Resources Defense Council, Washington, DC, USA.; George Washington University, Washington, DC, USA., Sepai O; UK Health Security Agency, London, SE1 8UG, UK., Simanainen U; European Chemicals Agency, Helsinki, Finland., Thayer KA; Center for Public Health and Environmental Assessment, Chemical and Pollutant Assessment Division (CPAD), U.S. EPA, Durham, NC, USA., Tong W; National Center for Toxicological Research of US Food and Drug Administration, Jefferson, AR, USA., Wikoff D; ToxStrategies, Asheville, NC, USA., Wright F; Departments of Statistics and Biological Sciences and Bioinformatics Research Center, North Carolina State University, Raleigh, NC, USA., Whaley P; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway. paul@whaleyresearch.uk.; Lancaster Environment Centre, Lancaster University, Lancaster, UK. paul@whaleyresearch.uk.
Publikováno v:
Archives of toxicology [Arch Toxicol] 2024 Aug; Vol. 98 (8), pp. 2299-2308. Date of Electronic Publication: 2024 Jun 14.
Autor:
Leuzy A; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA.; Enigma Biomedical Group, Knoxville, Tennessee, USA., Raket LL; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Eli Lilly and Company, Indianapolis, Indiana, USA., Villemagne VL; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Florey Department of Neuroscience, University of Melbourne, Parkville, Victoria, Australia.; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia., Klein G; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Tonietto M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Olafson E; Clinical Imaging Group, Genentech, Inc., South San Francisco, California, USA., Baker S; Lawrence Berkeley National Laboratory, Berkeley, California, USA., Saad ZS; Janssen Research & Development, Merryfield Row San Diego, California, USA., Bullich S; Life Molecular Imaging GmbH, Berlin, Germany., Lopresti B; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Bohorquez SS; Clinical Imaging Group, Genentech, Inc., South San Francisco, California, USA., Boada M; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Av. de Monforte de Lemos, Madrid, Spain., Betthauser TJ; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Physics, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA., Charil A; Eisai, Inc., Nutley, New Jersey, USA., Collins EC; Eli Lilly and Company, Indianapolis, Indiana, USA., Collins JA; Biogen, Cambridge, Massachusetts, USA., Cullen N; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA., Gunn RN; Invicro, Hammersmith Hospital, London, UK.; Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Higuchi M; Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Inage-ku, Chiba-shi, Chiba, Japan., Hostetler E; Merck & Co., Inc, West Point, Pennsylvania, USA., Hutchison RM; Biogen, Cambridge, Massachusetts, USA., Iaccarino L; Eli Lilly and Company, Indianapolis, Indiana, USA., Insel PS; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California, USA., Irizarry MC; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Jack CR Jr; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA., Jagust WJ; University of California Berkeley, Lawrence Berkeley National Laboratory, Berkeley, California, USA., Johnson KA; Harvard Medical School, Department of Radiology, Boston, Minnesota, USA.; Gordon Center for Medical Imaging, Massachusetts General Hospital, Boston, Minnesota, USA., Johnson SC; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Physics, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA., Karten Y; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA., Marquié M; Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Physics, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA., Mathotaarachchi S; Enigma Biomedical Group, Knoxville, Tennessee, USA., Mintun MA; Eli Lilly and Company, Indianapolis, Indiana, USA., Ossenkoppele R; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Amsterdam University Medical Center, Neuroscience Campus Amsterdam, Alzheimercenter, HZ Amsterdam, the Netherlands., Pappas I; Department of Psychology, Helen Wills Neuroscience Institute, University of California, Berkeley, California, USA.; Department of Neurology, VA Northern California Health Care System, Martinez, California, USA., Petersen RC; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Rabinovici GD; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.; Department of Radiology & Biomedical Imaging, University of California, San Francisco, California, USA., Rosa-Neto P; Translational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill University, Verdun, Quebec, Canada.; Montreal Neurological Institute, McGill University, Montréal, Québec, Canada., Schwarz CG; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA., Smith R; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Neurology, Skåne University Hospital, Lund, Sweden., Stephens AW; Life Molecular Imaging GmbH, Berlin, Germany., Whittington A; Invicro, Hammersmith Hospital, London, UK., Carrillo MC; Alzheimer's Association, Chicago, Illinois, USA., Pontecorvo MJ; Eli Lilly and Company, Indianapolis, Indiana, USA., Haeberlein SB; Enigma Biomedical Group, Knoxville, Tennessee, USA., Dunn B; Senior advisor to CPAD Consortium, Critical Path Institute, Tucson, Arizona, USA., Kolb HC; Enigma Biomedical Group, Knoxville, Tennessee, USA., Sivakumaran S; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA., Rowe CC; Florey Department of Neuroscience, University of Melbourne, Parkville, Victoria, Australia.; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia.; The Australian Dementia Network (ADNeT), The University of Melbourne, Parkville, Victoria, Australia., Hansson O; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, Malmö, Sweden., Doré V; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia.; Health and Biosecurity Flagship, The Australian eHealth Research Centre, CSIRO, Parkville, Victoria, Australia.
Publikováno v:
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Jul 23. Date of Electronic Publication: 2024 Jul 23.
Autor:
Shirke AV; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division (CPAD), US Environmental Protection Agency (US EPA), Washington, DC, USA., Radke EG; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division (CPAD), US Environmental Protection Agency (US EPA), Washington, DC, USA., Lin C; ICF International, Fairfax, Virginia, USA., Blain R; ICF International, Fairfax, Virginia, USA., Vetter N; ICF International, Fairfax, Virginia, USA., Lemeris C; ICF International, Fairfax, Virginia, USA., Hartman P; ICF International, Fairfax, Virginia, USA., Hubbard H; ICF International, Fairfax, Virginia, USA., Angrish M; CPAD, US EPA, Durham, North Carolina, USA., Arzuaga X; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division (CPAD), US Environmental Protection Agency (US EPA), Washington, DC, USA., Congleton J; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division (CPAD), US Environmental Protection Agency (US EPA), Washington, DC, USA., Davis A; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division (CPAD), US Environmental Protection Agency (US EPA), Washington, DC, USA., Dishaw LV; CPAD, US EPA, Durham, North Carolina, USA., Jones R; Center for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division (HEEAD), US EPA, Durham, North Carolina, USA., Judson R; Center for Computational Toxicology and Exposure (CCTE), US EPA, Durham, North Carolina, USA., Kaiser JP; CPAD, US EPA, Cincinnati, Ohio, USA., Kraft A; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division (CPAD), US Environmental Protection Agency (US EPA), Washington, DC, USA., Lizarraga L; CPAD, US EPA, Cincinnati, Ohio, USA., Noyes PD; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division (CPAD), US Environmental Protection Agency (US EPA), Washington, DC, USA., Patlewicz G; Center for Computational Toxicology and Exposure (CCTE), US EPA, Durham, North Carolina, USA., Taylor M; CPAD, US EPA, Durham, North Carolina, USA., Williams AJ; Center for Computational Toxicology and Exposure (CCTE), US EPA, Durham, North Carolina, USA., Thayer KA; CPAD, US EPA, Durham, North Carolina, USA., Carlson LM; Center for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division (HEEAD), US EPA, Durham, North Carolina, USA.
Publikováno v:
Environmental health perspectives [Environ Health Perspect] 2024 Feb; Vol. 132 (2), pp. 26001. Date of Electronic Publication: 2024 Feb 06.
Autor:
Gogola A; Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA., Cohen AD; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.; Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA., Snitz B; Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA., Minhas D; Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA., Tudorascu D; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.; Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA., Ikonomovic MD; Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.; Geriatric Research Education and Clinical Center, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, USA., Shaaban CE; Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA., Doré V; Department of Molecular Imaging & Therapy, Austin Health, Melbourne, VIC, Australia.; Commonwealth Scientific and Industrial Research Organisation Health & Biosecurity, Melbourne, VIC, Australia., Matan C; Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA., Bourgeat P; Commonwealth Scientific and Industrial Research Organisation Health & Biosecurity, Melbourne, VIC, Australia., Mason NS; Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA., Leuzy A; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, AZ, USA., Aizenstein H; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.; Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA., Mathis CA; Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA., Lopez OL; Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA., Lopresti BJ; Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA., Villemagne VL; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.; Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Molecular Imaging & Therapy, Austin Health, Melbourne, VIC, Australia.
Publikováno v:
Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2024; Vol. 100 (s1), pp. S75-S92.
Autor:
Keshava C; U.S. Environmental Protection Agency (US EPA), Office of Research and Development, Center for Public Health and Environmental Assessment (CPHEA), Chemical Pollutant Assessment Division (CPAD), 109 T.W. Alexander Dr, Research Triangle Park, NC 27711, USA. Electronic address: keshava.channa@epa.gov., Nicolai S; German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. Electronic address: Suna.Nicolai@bfr.bund.de., Vulimiri SV; U.S. Environmental Protection Agency (US EPA), Office of Research and Development, Center for Public Health and Environmental Assessment (CPHEA), Chemical Pollutant Assessment Division (CPAD), 109 T.W. Alexander Dr, Research Triangle Park, NC 27711, USA. Electronic address: vulimiri.sury@epa.gov., Cruz FA; German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany., Ghoreishi N; German Federal Institute for Risk Assessment (BfR), Department of Exposure, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. Electronic address: Narges.Ghoreishi@bfr.bund.de., Knueppel S; German Federal Institute for Risk Assessment (BfR), Department of Food Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. Electronic address: Sven.Knueppel@bfr.bund.de., Lenzner A; German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. Electronic address: Ariane.Lenzner@bfr.bund.de., Tarnow P; German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. Electronic address: Patrick.Tarnow@bfr.bund.de., Vanselow JT; German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. Electronic address: Jens.Vanselow@bfr.bund.de., Schulz B; Oak Ridge Associated Universities (ORAU), Environmental Protection Agency National Student Services Contract (EPA NSSC), 100 ORAU Way, Oak Ridge, TN 37830, USA. Electronic address: schulz.brittany@epa.gov., Persad A; U.S. Environmental Protection Agency (US EPA), Office of Research and Development, Center for Public Health and Environmental Assessment (CPHEA), Chemical Pollutant Assessment Division (CPAD), 109 T.W. Alexander Dr, Research Triangle Park, NC 27711, USA. Electronic address: persad.amanda@epa.gov., Baker N; Leidos, Research Triangle Park, NC 27711, USA. Electronic address: Baker.Nancy@epa.gov., Thayer KA; U.S. Environmental Protection Agency (US EPA), Office of Research and Development, Center for Public Health and Environmental Assessment (CPHEA), Chemical Pollutant Assessment Division (CPAD), 109 T.W. Alexander Dr, Research Triangle Park, NC 27711, USA. Electronic address: thayer.kris@epa.gov., Williams AJ; U.S. Environmental Protection Agency (US EPA), Office of Research and Development, Center for Computational Toxicology and Exposure (CCTE), Research Triangle Park, NC 27711, USA. Electronic address: Williams.Antony@epa.gov., Pirow R; German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. Electronic address: Ralph.Pirow@bfr.bund.de.
Publikováno v:
Environment international [Environ Int] 2023 Jun; Vol. 176, pp. 107952. Date of Electronic Publication: 2023 Apr 30.